State Key Laboratory of Microbial Technology, Shandong University, Qingdao, People's Republic of China.
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Department of Radiobiology, Institute of Radiation Medicine of Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, People's Republic of China.
mBio. 2019 Jul 30;10(4):e01570-19. doi: 10.1128/mBio.01570-19.
Glutarate, a metabolic intermediate in the catabolism of several amino acids and aromatic compounds, can be catabolized through both the glutarate hydroxylation pathway and the glutaryl-coenzyme A (glutaryl-CoA) dehydrogenation pathway in KT2440. The elucidation of the regulatory mechanism could greatly aid in the design of biotechnological alternatives for glutarate production. In this study, it was found that a GntR family protein, CsiR, and a LysR family protein, GcdR, regulate the catabolism of glutarate by repressing the transcription of and , two key genes in the glutarate hydroxylation pathway, and by activating the transcription of and , two key genes in the glutaryl-CoA dehydrogenation pathway, respectively. Our data suggest that CsiR and GcdR are independent and that there is no cross-regulation between the two pathways. l-2-Hydroxyglutarate (l-2-HG), a metabolic intermediate in the glutarate catabolism with various physiological functions, has never been elucidated in terms of its metabolic regulation. Here, we reveal that two molecules, glutarate and l-2-HG, act as effectors of CsiR and that KT2440 uses CsiR to sense glutarate and l-2-HG and to utilize them effectively. This report broadens our understanding of the bacterial regulatory mechanisms of glutarate and l-2-HG catabolism and may help to identify regulators of l-2-HG catabolism in other species. Glutarate is an attractive dicarboxylate with various applications. Clarification of the regulatory mechanism of glutarate catabolism could help to block the glutarate catabolic pathways, thereby improving glutarate production through biotechnological routes. Glutarate is a toxic metabolite in humans, and its accumulation leads to a hereditary metabolic disorder, glutaric aciduria type I. The elucidation of the functions of CsiR and GcdR as regulators that respond to glutarate could help in the design of glutarate biosensors for the rapid detection of glutarate in patients with glutaric aciduria type I. In addition, CsiR was identified as a regulator that also regulates l-2-HG metabolism. The identification of CsiR as a regulator that responds to l-2-HG could help in the discovery and investigation of other regulatory proteins involved in l-2-HG catabolism.
戊二酸盐是几种氨基酸和芳香族化合物分解代谢中的代谢中间产物,可通过 KT2440 中的戊二酸盐羟化途径和戊二酰辅酶 A(glutaryl-CoA)脱氢途径进行分解代谢。阐明调控机制将极大地有助于设计戊二酸盐生产的生物技术替代方案。在这项研究中,发现一种 GntR 家族蛋白 CsiR 和一种 LysR 家族蛋白 GcdR 通过抑制戊二酸盐羟化途径中的两个关键基因 和 的转录,以及激活戊二酰辅酶 A 脱氢途径中的两个关键基因 和 的转录来调节戊二酸盐的分解代谢。我们的数据表明,CsiR 和 GcdR 是独立的,两种途径之间没有交叉调控。L-2-羟基戊二酸(L-2-HG)是戊二酸盐分解代谢中的一种代谢中间产物,具有多种生理功能,但它的代谢调控从未被阐明。在这里,我们揭示了两种分子,戊二酸盐和 L-2-HG,作为 CsiR 的效应物,并且 KT2440 利用 CsiR 来感知戊二酸盐和 L-2-HG 并有效地利用它们。本报告拓宽了我们对细菌戊二酸盐和 L-2-HG 分解代谢调控机制的理解,并可能有助于鉴定其他物种中 L-2-HG 分解代谢的调节剂。戊二酸盐是一种具有多种应用的有吸引力的二羧酸。阐明戊二酸盐分解代谢的调控机制有助于阻断戊二酸盐分解代谢途径,从而通过生物技术途径提高戊二酸盐的产量。戊二酸盐在人类中是一种有毒的代谢物,其积累会导致遗传性代谢紊乱,即 I 型戊二酸血症。阐明 CsiR 和 GcdR 作为响应戊二酸盐的调节剂的功能有助于设计戊二酸盐生物传感器,以便快速检测 I 型戊二酸血症患者的戊二酸盐。此外,CsiR 被鉴定为一种调节 L-2-HG 代谢的调节剂。鉴定 CsiR 为响应 L-2-HG 的调节剂有助于发现和研究其他参与 L-2-HG 分解代谢的调节蛋白。